M2M with Ravi Ananthanarayanan
Mint
Mint
  • 6 years ago
Ranbaxy Laboratories should have seen its shares soar with its launch of a generic version of the drug Lipitor in the US. So why are investors not enthused?
Recommended
1:38
I
Up next
M2M with Mobis Philipose
Mint
1:24
M2M on IT Services Sector
Mint
1:09
M2M on State Electricity Boards
Mint
2:08
Interview: Ravi Venkatesh, Director, Infosys
Mint
3:01
Ravi Shastri is the new team India coach
Mint
2:02
India is rising in the field of digital economy: Ravi Shankar Prasad
Mint
3:07
NGT clears deck for Sri Sri Ravi Shankar’s Art of Living event, slaps Rs5 Crore fine
Mint
1:41
Khaitan & Co Partner Ravi Kulkarni | Women on Board
Mint
0:35
BJP's Ravi Shankar Prasad on forming a stable government
Mint
0:39
Remembering Pandit Ravi Shankar on his 96th birthday
Mint
2:35
Artists At Work | Ravi Subramanian
Mint
Transformation Agenda 2020 by Mint and Danfoss : India's climate imperatives
Mint
3:14
Interview: Manipur's, Chief Electoral Officer, P.C. Lawkunga
Mint
2:23
Closing Bell
Mint
3:09
Deals Space
Mint
2:09
Tough times ahead for firms with high leverage
Mint
1:53
Marriages and Indonesia’s Food Waste Problem
Mint
1:28
Trump meets Singapore PM ahead of historic Summit with Kim Jong Un
Mint
1:41
The rise, fall and return of Jagmohan Dalmiya
Mint
1:51
Bihar polls: Modi, Nitish Kumar make last-minute push with 10 rallies
Mint
Mint
6:52
Jet Airways crisis: Who is to blame, lending banks or promoter Naresh Goyal?
Mint
1:38
What to expect from Reliance Q4 earnings?
Mint
29:58
Zia Mody on adversarial deal making, fear of missing out in private equity
Mint
19:20
Apex Court squashes RBI's Feb 12 Circular on Stressed Assets Resolution : A Decode
Mint
12:50
Marico Founder Harsh Mariwala on how Indian start-ups can scale up & thrive
Mint
23:10
'Hostile' takeovers: L&T-Mindtree saga signals new era in Indian M&A deals?
Mint
Featured channels
More from
HW News Network
More from
OutlookIndia
More from
HW News English
More from
HW News Marathi
More from
Comedy Tadka
More from
Tuk Tuk TV